Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension

NCT02426177 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2015-04-24

No results posted yet for this study

Summary

To compare effectiveness of oral labetalol and oral nifedipine for management of postpartum hypertension.

Conditions

  • Postnatal Hypertension

Interventions

DRUG

Labetalol

anti-hypertensive agents

DRUG

Nifedipine

calcium channel blocker ,for lowering blood pressure

Sponsors & Collaborators

  • Dow University of Health Sciences

    lead OTHER

Principal Investigators

  • fariha javed, mbbs · Dow University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-05-31
Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02426177 on ClinicalTrials.gov